According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Medical Biomedical Materials 3.0 - Market

The third generation of biological materials: the biological active materials and biodegradable materials, to combine these two independent concepts in modification of biodegradable materials, combined with cell integrin, induction of cell proliferation, differentiation, and the synthesis of extracellular matrix and assembly, so as to start the regeneration system of the body, belong to the category of regenerative medicine.The third generation of biomaterials is represented by tissue engineering scaffold materials, in-situ tissue regeneration materials, degradable composite cells and/or growth factor materials.

The global market for Medical Biomedical Materials 3.0 was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Medical Biomedical Materials 3.0, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Medical Biomedical Materials 3.0 by region & country, by Type, and by Application.

The Medical Biomedical Materials 3.0 market size, estimations, and forecasts are provided in terms of sales volume (Ton) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Biomedical Materials 3.0.

Market Segmentation

Scope of Medical Biomedical Materials 3.0 - Market Report

Report Metric	Details
Report Name	Medical Biomedical Materials 3.0 - Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type:	PLA PGA PLGA PLCG Other
Segment by Application	Suture Fracture Fixation Oral Implant Drug Delivery Microsphere Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, PCAS, Fujifilm, Evonik Health Care, Nomisma Healthcare, Corbion, DURECT, Mitsui Chemicals, Phosphorex Inc., Lattice Medical, Jinan Daigang Biomaterial, Shenzhen Polymtek Biomaterial Co., Ltd., Changchun Foliaplast Bio-tech Co., Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Biomedical Materials 3.0 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Medical Biomedical Materials 3.0 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Medical Biomedical Materials 3.0 in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Medical Biomedical Materials 3.0 - Market report?

Ans: The main players in the Medical Biomedical Materials 3.0 - Market are Merck, PCAS, Fujifilm, Evonik Health Care, Nomisma Healthcare, Corbion, DURECT, Mitsui Chemicals, Phosphorex Inc., Lattice Medical, Jinan Daigang Biomaterial, Shenzhen Polymtek Biomaterial Co., Ltd., Changchun Foliaplast Bio-tech Co., Ltd

What are the Application segmentation covered in the Medical Biomedical Materials 3.0 - Market report?

Ans: The Applications covered in the Medical Biomedical Materials 3.0 - Market report are Suture, Fracture Fixation, Oral Implant, Drug Delivery Microsphere, Others

What are the Type segmentation covered in the Medical Biomedical Materials 3.0 - Market report?

Ans: The Types covered in the Medical Biomedical Materials 3.0 - Market report are PLA, PGA, PLGA, PLCG, Other

1 Market Overview

1.1 Medical Biomedical Materials 3.0 Product Introduction

1.2 Global Medical Biomedical Materials 3.0 Market Size Forecast

1.2.1 Global Medical Biomedical Materials 3.0 Sales Value (2019-2030)

1.2.2 Global Medical Biomedical Materials 3.0 Sales Volume (2019-2030)

1.2.3 Global Medical Biomedical Materials 3.0 Sales Price (2019-2030)

1.3 Medical Biomedical Materials 3.0 Market Trends & Drivers

1.3.1 Medical Biomedical Materials 3.0 Industry Trends

1.3.2 Medical Biomedical Materials 3.0 Market Drivers & Opportunity

1.3.3 Medical Biomedical Materials 3.0 Market Challenges

1.3.4 Medical Biomedical Materials 3.0 Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Medical Biomedical Materials 3.0 Players Revenue Ranking (2023)

2.2 Global Medical Biomedical Materials 3.0 Revenue by Company (2019-2024)

2.3 Global Medical Biomedical Materials 3.0 Players Sales Volume Ranking (2023)

2.4 Global Medical Biomedical Materials 3.0 Sales Volume by Company Players (2019-2024)

2.5 Global Medical Biomedical Materials 3.0 Average Price by Company (2019-2024)

2.6 Key Manufacturers Medical Biomedical Materials 3.0 Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Medical Biomedical Materials 3.0 Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Medical Biomedical Materials 3.0

2.9 Medical Biomedical Materials 3.0 Market Competitive Analysis

2.9.1 Medical Biomedical Materials 3.0 Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Medical Biomedical Materials 3.0 Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Biomedical Materials 3.0 as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 PLA

3.1.2 PGA

3.1.3 PLGA

3.1.4 PLCG

3.1.5 Other

3.2 Global Medical Biomedical Materials 3.0 Sales Value by Type

3.2.1 Global Medical Biomedical Materials 3.0 Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Medical Biomedical Materials 3.0 Sales Value, by Type (2019-2030)

3.2.3 Global Medical Biomedical Materials 3.0 Sales Value, by Type (%) (2019-2030)

3.3 Global Medical Biomedical Materials 3.0 Sales Volume by Type

3.3.1 Global Medical Biomedical Materials 3.0 Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Medical Biomedical Materials 3.0 Sales Volume, by Type (2019-2030)

3.3.3 Global Medical Biomedical Materials 3.0 Sales Volume, by Type (%) (2019-2030)

3.4 Global Medical Biomedical Materials 3.0 Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Suture

4.1.2 Fracture Fixation

4.1.3 Oral Implant

4.1.4 Drug Delivery Microsphere

4.1.5 Others

4.2 Global Medical Biomedical Materials 3.0 Sales Value by Application

4.2.1 Global Medical Biomedical Materials 3.0 Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Medical Biomedical Materials 3.0 Sales Value, by Application (2019-2030)

4.2.3 Global Medical Biomedical Materials 3.0 Sales Value, by Application (%) (2019-2030)

4.3 Global Medical Biomedical Materials 3.0 Sales Volume by Application

4.3.1 Global Medical Biomedical Materials 3.0 Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Medical Biomedical Materials 3.0 Sales Volume, by Application (2019-2030)

4.3.3 Global Medical Biomedical Materials 3.0 Sales Volume, by Application (%) (2019-2030)

4.4 Global Medical Biomedical Materials 3.0 Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Medical Biomedical Materials 3.0 Sales Value by Region

5.1.1 Global Medical Biomedical Materials 3.0 Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Medical Biomedical Materials 3.0 Sales Value by Region (2019-2024)

5.1.3 Global Medical Biomedical Materials 3.0 Sales Value by Region (2025-2030)

5.1.4 Global Medical Biomedical Materials 3.0 Sales Value by Region (%), (2019-2030)

5.2 Global Medical Biomedical Materials 3.0 Sales Volume by Region

5.2.1 Global Medical Biomedical Materials 3.0 Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Medical Biomedical Materials 3.0 Sales Volume by Region (2019-2024)

5.2.3 Global Medical Biomedical Materials 3.0 Sales Volume by Region (2025-2030)

5.2.4 Global Medical Biomedical Materials 3.0 Sales Volume by Region (%), (2019-2030)

5.3 Global Medical Biomedical Materials 3.0 Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Medical Biomedical Materials 3.0 Sales Value, 2019-2030

5.4.2 North America Medical Biomedical Materials 3.0 Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Medical Biomedical Materials 3.0 Sales Value, 2019-2030

5.5.2 Europe Medical Biomedical Materials 3.0 Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Medical Biomedical Materials 3.0 Sales Value, 2019-2030

5.6.2 Asia Pacific Medical Biomedical Materials 3.0 Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Medical Biomedical Materials 3.0 Sales Value, 2019-2030

5.7.2 South America Medical Biomedical Materials 3.0 Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Medical Biomedical Materials 3.0 Sales Value, 2019-2030

5.8.2 Middle East & Africa Medical Biomedical Materials 3.0 Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Medical Biomedical Materials 3.0 Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Medical Biomedical Materials 3.0 Sales Value

6.2.1 Key Countries/Regions Medical Biomedical Materials 3.0 Sales Value, 2019-2030

6.2.2 Key Countries/Regions Medical Biomedical Materials 3.0 Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Medical Biomedical Materials 3.0 Sales Value, 2019-2030

6.3.2 United States Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Medical Biomedical Materials 3.0 Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Medical Biomedical Materials 3.0 Sales Value, 2019-2030

6.4.2 Europe Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Medical Biomedical Materials 3.0 Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Medical Biomedical Materials 3.0 Sales Value, 2019-2030

6.5.2 China Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

6.5.3 China Medical Biomedical Materials 3.0 Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Medical Biomedical Materials 3.0 Sales Value, 2019-2030

6.6.2 Japan Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Medical Biomedical Materials 3.0 Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Medical Biomedical Materials 3.0 Sales Value, 2019-2030

6.7.2 South Korea Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Medical Biomedical Materials 3.0 Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Medical Biomedical Materials 3.0 Sales Value, 2019-2030

6.8.2 Southeast Asia Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Medical Biomedical Materials 3.0 Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Medical Biomedical Materials 3.0 Sales Value, 2019-2030

6.9.2 India Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

6.9.3 India Medical Biomedical Materials 3.0 Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Merck

7.1.1 Merck Company Information

7.1.2 Merck Introduction and Business Overview

7.1.3 Merck Medical Biomedical Materials 3.0 Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Merck Medical Biomedical Materials 3.0 Product Offerings

7.1.5 Merck Recent Development

7.2 PCAS

7.2.1 PCAS Company Information

7.2.2 PCAS Introduction and Business Overview

7.2.3 PCAS Medical Biomedical Materials 3.0 Sales, Revenue and Gross Margin (2019-2024)

7.2.4 PCAS Medical Biomedical Materials 3.0 Product Offerings

7.2.5 PCAS Recent Development

7.3 Fujifilm

7.3.1 Fujifilm Company Information

7.3.2 Fujifilm Introduction and Business Overview

7.3.3 Fujifilm Medical Biomedical Materials 3.0 Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Fujifilm Medical Biomedical Materials 3.0 Product Offerings

7.3.5 Fujifilm Recent Development

7.4 Evonik Health Care

7.4.1 Evonik Health Care Company Information

7.4.2 Evonik Health Care Introduction and Business Overview

7.4.3 Evonik Health Care Medical Biomedical Materials 3.0 Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Evonik Health Care Medical Biomedical Materials 3.0 Product Offerings

7.4.5 Evonik Health Care Recent Development

7.5 Nomisma Healthcare

7.5.1 Nomisma Healthcare Company Information

7.5.2 Nomisma Healthcare Introduction and Business Overview

7.5.3 Nomisma Healthcare Medical Biomedical Materials 3.0 Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Nomisma Healthcare Medical Biomedical Materials 3.0 Product Offerings

7.5.5 Nomisma Healthcare Recent Development

7.6 Corbion

7.6.1 Corbion Company Information

7.6.2 Corbion Introduction and Business Overview

7.6.3 Corbion Medical Biomedical Materials 3.0 Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Corbion Medical Biomedical Materials 3.0 Product Offerings

7.6.5 Corbion Recent Development

7.7 DURECT

7.7.1 DURECT Company Information

7.7.2 DURECT Introduction and Business Overview

7.7.3 DURECT Medical Biomedical Materials 3.0 Sales, Revenue and Gross Margin (2019-2024)

7.7.4 DURECT Medical Biomedical Materials 3.0 Product Offerings

7.7.5 DURECT Recent Development

7.8 Mitsui Chemicals

7.8.1 Mitsui Chemicals Company Information

7.8.2 Mitsui Chemicals Introduction and Business Overview

7.8.3 Mitsui Chemicals Medical Biomedical Materials 3.0 Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Mitsui Chemicals Medical Biomedical Materials 3.0 Product Offerings

7.8.5 Mitsui Chemicals Recent Development

7.9 Phosphorex Inc.

7.9.1 Phosphorex Inc. Company Information

7.9.2 Phosphorex Inc. Introduction and Business Overview

7.9.3 Phosphorex Inc. Medical Biomedical Materials 3.0 Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Phosphorex Inc. Medical Biomedical Materials 3.0 Product Offerings

7.9.5 Phosphorex Inc. Recent Development

7.10 Lattice Medical

7.10.1 Lattice Medical Company Information

7.10.2 Lattice Medical Introduction and Business Overview

7.10.3 Lattice Medical Medical Biomedical Materials 3.0 Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Lattice Medical Medical Biomedical Materials 3.0 Product Offerings

7.10.5 Lattice Medical Recent Development

7.11 Jinan Daigang Biomaterial

7.11.1 Jinan Daigang Biomaterial Company Information

7.11.2 Jinan Daigang Biomaterial Introduction and Business Overview

7.11.3 Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Product Offerings

7.11.5 Jinan Daigang Biomaterial Recent Development

7.12 Shenzhen Polymtek Biomaterial Co., Ltd.

7.12.1 Shenzhen Polymtek Biomaterial Co., Ltd. Company Information

7.12.2 Shenzhen Polymtek Biomaterial Co., Ltd. Introduction and Business Overview

7.12.3 Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Product Offerings

7.12.5 Shenzhen Polymtek Biomaterial Co., Ltd. Recent Development

7.13 Changchun Foliaplast Bio-tech Co., Ltd

7.13.1 Changchun Foliaplast Bio-tech Co., Ltd Company Information

7.13.2 Changchun Foliaplast Bio-tech Co., Ltd Introduction and Business Overview

7.13.3 Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Product Offerings

7.13.5 Changchun Foliaplast Bio-tech Co., Ltd Recent Development

8 Industry Chain Analysis

8.1 Medical Biomedical Materials 3.0 Industrial Chain

8.2 Medical Biomedical Materials 3.0 Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Medical Biomedical Materials 3.0 Sales Model

8.5.2 Sales Channel

8.5.3 Medical Biomedical Materials 3.0 Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Jinan Daigang Biomaterial

Shenzhen Polymtek Biomaterial Co., Ltd.

Changchun Foliaplast Bio-tech Co., Ltd

List of Tables

Table 1. Medical Biomedical Materials 3.0 Market Trends

Table 2. Medical Biomedical Materials 3.0 Market Drivers & Opportunity

Table 3. Medical Biomedical Materials 3.0 Market Challenges

Table 4. Medical Biomedical Materials 3.0 Market Restraints

Table 5. Global Medical Biomedical Materials 3.0 Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Medical Biomedical Materials 3.0 Revenue Market Share by Company (2019-2024)

Table 7. Global Medical Biomedical Materials 3.0 Sales Volume by Company (2019-2024) & (Ton)

Table 8. Global Medical Biomedical Materials 3.0 Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Medical Biomedical Materials 3.0 Price by Company (2019-2024) & (US$/Ton)

Table 10. Key Manufacturers Medical Biomedical Materials 3.0 Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Medical Biomedical Materials 3.0 Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Medical Biomedical Materials 3.0

Table 13. Global Medical Biomedical Materials 3.0 Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Biomedical Materials 3.0 as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Medical Biomedical Materials 3.0 Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Medical Biomedical Materials 3.0 Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Medical Biomedical Materials 3.0 Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Medical Biomedical Materials 3.0 Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Medical Biomedical Materials 3.0 Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Medical Biomedical Materials 3.0 Sales Volume by Type: 2019 VS 2023 VS 2030 (Ton)

Table 22. Global Medical Biomedical Materials 3.0 Sales Volume by Type (2019-2024) & (Ton)

Table 23. Global Medical Biomedical Materials 3.0 Sales Volume by Type (2025-2030) & (Ton)

Table 24. Global Medical Biomedical Materials 3.0 Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Medical Biomedical Materials 3.0 Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Medical Biomedical Materials 3.0 Price by Type (2019-2024) & (US$/Ton)

Table 27. Global Medical Biomedical Materials 3.0 Price by Type (2025-2030) & (US$/Ton)

Table 28. Global Medical Biomedical Materials 3.0 Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Medical Biomedical Materials 3.0 Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Medical Biomedical Materials 3.0 Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Medical Biomedical Materials 3.0 Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Medical Biomedical Materials 3.0 Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Medical Biomedical Materials 3.0 Sales Volume by Application: 2019 VS 2023 VS 2030 (Ton)

Table 34. Global Medical Biomedical Materials 3.0 Sales Volume by Application (2019-2024) & (Ton)

Table 35. Global Medical Biomedical Materials 3.0 Sales Volume by Application (2025-2030) & (Ton)

Table 36. Global Medical Biomedical Materials 3.0 Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Medical Biomedical Materials 3.0 Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Medical Biomedical Materials 3.0 Price by Application (2019-2024) & (US$/Ton)

Table 39. Global Medical Biomedical Materials 3.0 Price by Application (2025-2030) & (US$/Ton)

Table 40. Global Medical Biomedical Materials 3.0 Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Medical Biomedical Materials 3.0 Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Medical Biomedical Materials 3.0 Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Medical Biomedical Materials 3.0 Sales Value by Region (2019-2024) & (%)

Table 44. Global Medical Biomedical Materials 3.0 Sales Value by Region (2025-2030) & (%)

Table 45. Global Medical Biomedical Materials 3.0 Sales Volume by Region (Ton): 2019 VS 2023 VS 2030

Table 46. Global Medical Biomedical Materials 3.0 Sales Volume by Region (2019-2024) & (Ton)

Table 47. Global Medical Biomedical Materials 3.0 Sales Volume by Region (2025-2030) & (Ton)

Table 48. Global Medical Biomedical Materials 3.0 Sales Volume by Region (2019-2024) & (%)

Table 49. Global Medical Biomedical Materials 3.0 Sales Volume by Region (2025-2030) & (%)

Table 50. Global Medical Biomedical Materials 3.0 Average Price by Region (2019-2024) & (US$/Ton)

Table 51. Global Medical Biomedical Materials 3.0 Average Price by Region (2025-2030) & (US$/Ton)

Table 52. Key Countries/Regions Medical Biomedical Materials 3.0 Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Medical Biomedical Materials 3.0 Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Medical Biomedical Materials 3.0 Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Medical Biomedical Materials 3.0 Sales Volume, (2019-2024) & (Ton)

Table 56. Key Countries/Regions Medical Biomedical Materials 3.0 Sales Volume, (2025-2030) & (Ton)

Table 57. Merck Company Information

Table 58. Merck Introduction and Business Overview

Table 59. Merck Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 60. Merck Medical Biomedical Materials 3.0 Product Offerings

Table 61. Merck Recent Development

Table 62. PCAS Company Information

Table 63. PCAS Introduction and Business Overview

Table 64. PCAS Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 65. PCAS Medical Biomedical Materials 3.0 Product Offerings

Table 66. PCAS Recent Development

Table 67. Fujifilm Company Information

Table 68. Fujifilm Introduction and Business Overview

Table 69. Fujifilm Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 70. Fujifilm Medical Biomedical Materials 3.0 Product Offerings

Table 71. Fujifilm Recent Development

Table 72. Evonik Health Care Company Information

Table 73. Evonik Health Care Introduction and Business Overview

Table 74. Evonik Health Care Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 75. Evonik Health Care Medical Biomedical Materials 3.0 Product Offerings

Table 76. Evonik Health Care Recent Development

Table 77. Nomisma Healthcare Company Information

Table 78. Nomisma Healthcare Introduction and Business Overview

Table 79. Nomisma Healthcare Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 80. Nomisma Healthcare Medical Biomedical Materials 3.0 Product Offerings

Table 81. Nomisma Healthcare Recent Development

Table 82. Corbion Company Information

Table 83. Corbion Introduction and Business Overview

Table 84. Corbion Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 85. Corbion Medical Biomedical Materials 3.0 Product Offerings

Table 86. Corbion Recent Development

Table 87. DURECT Company Information

Table 88. DURECT Introduction and Business Overview

Table 89. DURECT Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 90. DURECT Medical Biomedical Materials 3.0 Product Offerings

Table 91. DURECT Recent Development

Table 92. Mitsui Chemicals Company Information

Table 93. Mitsui Chemicals Introduction and Business Overview

Table 94. Mitsui Chemicals Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 95. Mitsui Chemicals Medical Biomedical Materials 3.0 Product Offerings

Table 96. Mitsui Chemicals Recent Development

Table 97. Phosphorex Inc. Company Information

Table 98. Phosphorex Inc. Introduction and Business Overview

Table 99. Phosphorex Inc. Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 100. Phosphorex Inc. Medical Biomedical Materials 3.0 Product Offerings

Table 101. Phosphorex Inc. Recent Development

Table 102. Lattice Medical Company Information

Table 103. Lattice Medical Introduction and Business Overview

Table 104. Lattice Medical Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 105. Lattice Medical Medical Biomedical Materials 3.0 Product Offerings

Table 106. Lattice Medical Recent Development

Table 107. Jinan Daigang Biomaterial Company Information

Table 108. Jinan Daigang Biomaterial Introduction and Business Overview

Table 109. Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 110. Jinan Daigang Biomaterial Medical Biomedical Materials 3.0 Product Offerings

Table 111. Jinan Daigang Biomaterial Recent Development

Table 112. Shenzhen Polymtek Biomaterial Co., Ltd. Company Information

Table 113. Shenzhen Polymtek Biomaterial Co., Ltd. Introduction and Business Overview

Table 114. Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 115. Shenzhen Polymtek Biomaterial Co., Ltd. Medical Biomedical Materials 3.0 Product Offerings

Table 116. Shenzhen Polymtek Biomaterial Co., Ltd. Recent Development

Table 117. Changchun Foliaplast Bio-tech Co., Ltd Company Information

Table 118. Changchun Foliaplast Bio-tech Co., Ltd Introduction and Business Overview

Table 119. Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Sales (Ton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)

Table 120. Changchun Foliaplast Bio-tech Co., Ltd Medical Biomedical Materials 3.0 Product Offerings

Table 121. Changchun Foliaplast Bio-tech Co., Ltd Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Medical Biomedical Materials 3.0 Downstream Customers

Table 125. Medical Biomedical Materials 3.0 Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Medical Biomedical Materials 3.0 Product Picture

Figure 2. Global Medical Biomedical Materials 3.0 Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Medical Biomedical Materials 3.0 Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Medical Biomedical Materials 3.0 Sales Volume (2019-2030) & (Ton)

Figure 5. Global Medical Biomedical Materials 3.0 Sales Price (2019-2030) & (US$/Ton)

Figure 6. Medical Biomedical Materials 3.0 Report Years Considered

Figure 7. Global Medical Biomedical Materials 3.0 Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Medical Biomedical Materials 3.0 Players Sales Volume Ranking (2023) & (Ton)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Medical Biomedical Materials 3.0 Revenue in 2023

Figure 10. Medical Biomedical Materials 3.0 Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. PLA Picture

Figure 12. PGA Picture

Figure 13. PLGA Picture

Figure 14. PLCG Picture

Figure 15. Other Picture

Figure 16. Global Medical Biomedical Materials 3.0 Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 17. Global Medical Biomedical Materials 3.0 Sales Value Market Share by Type, 2023 & 2030

Figure 18. Global Medical Biomedical Materials 3.0 Sales Volume by Type (2019 VS 2023 VS 2030) & (Ton)

Figure 19. Global Medical Biomedical Materials 3.0 Sales Volume Market Share by Type, 2023 & 2030

Figure 20. Global Medical Biomedical Materials 3.0 Price by Type (2019-2030) & (US$/Ton)

Figure 21. Product Picture of Suture

Figure 22. Product Picture of Fracture Fixation

Figure 23. Product Picture of Oral Implant

Figure 24. Product Picture of Drug Delivery Microsphere

Figure 25. Product Picture of Others

Figure 26. Global Medical Biomedical Materials 3.0 Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 27. Global Medical Biomedical Materials 3.0 Sales Value Market Share by Application, 2023 & 2030

Figure 28. Global Medical Biomedical Materials 3.0 Sales Volume by Application (2019 VS 2023 VS 2030) & (Ton)

Figure 29. Global Medical Biomedical Materials 3.0 Sales Volume Market Share by Application, 2023 & 2030

Figure 30. Global Medical Biomedical Materials 3.0 Price by Application (2019-2030) & (US$/Ton)

Figure 31. North America Medical Biomedical Materials 3.0 Sales Value (2019-2030) & (US$ Million)

Figure 32. North America Medical Biomedical Materials 3.0 Sales Value by Country (%), 2023 VS 2030

Figure 33. Europe Medical Biomedical Materials 3.0 Sales Value (2019-2030) & (US$ Million)

Figure 34. Europe Medical Biomedical Materials 3.0 Sales Value by Country (%), 2023 VS 2030

Figure 35. Asia Pacific Medical Biomedical Materials 3.0 Sales Value (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Medical Biomedical Materials 3.0 Sales Value by Country (%), 2023 VS 2030

Figure 37. South America Medical Biomedical Materials 3.0 Sales Value (2019-2030) & (US$ Million)

Figure 38. South America Medical Biomedical Materials 3.0 Sales Value by Country (%), 2023 VS 2030

Figure 39. Middle East & Africa Medical Biomedical Materials 3.0 Sales Value (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Medical Biomedical Materials 3.0 Sales Value by Country (%), 2023 VS 2030

Figure 41. Key Countries/Regions Medical Biomedical Materials 3.0 Sales Value (%), (2019-2030)

Figure 42. Key Countries/Regions Medical Biomedical Materials 3.0 Sales Volume (%), (2019-2030)

Figure 43. United States Medical Biomedical Materials 3.0 Sales Value, (2019-2030) & (US$ Million)

Figure 44. United States Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

Figure 45. United States Medical Biomedical Materials 3.0 Sales Value by Application (%), 2023 VS 2030

Figure 46. Europe Medical Biomedical Materials 3.0 Sales Value, (2019-2030) & (US$ Million)

Figure 47. Europe Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

Figure 48. Europe Medical Biomedical Materials 3.0 Sales Value by Application (%), 2023 VS 2030

Figure 49. China Medical Biomedical Materials 3.0 Sales Value, (2019-2030) & (US$ Million)

Figure 50. China Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

Figure 51. China Medical Biomedical Materials 3.0 Sales Value by Application (%), 2023 VS 2030

Figure 52. Japan Medical Biomedical Materials 3.0 Sales Value, (2019-2030) & (US$ Million)

Figure 53. Japan Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

Figure 54. Japan Medical Biomedical Materials 3.0 Sales Value by Application (%), 2023 VS 2030

Figure 55. South Korea Medical Biomedical Materials 3.0 Sales Value, (2019-2030) & (US$ Million)

Figure 56. South Korea Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

Figure 57. South Korea Medical Biomedical Materials 3.0 Sales Value by Application (%), 2023 VS 2030

Figure 58. Southeast Asia Medical Biomedical Materials 3.0 Sales Value, (2019-2030) & (US$ Million)

Figure 59. Southeast Asia Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

Figure 60. Southeast Asia Medical Biomedical Materials 3.0 Sales Value by Application (%), 2023 VS 2030

Figure 61. India Medical Biomedical Materials 3.0 Sales Value, (2019-2030) & (US$ Million)

Figure 62. India Medical Biomedical Materials 3.0 Sales Value by Type (%), 2023 VS 2030

Figure 63. India Medical Biomedical Materials 3.0 Sales Value by Application (%), 2023 VS 2030

Figure 64. Medical Biomedical Materials 3.0 Industrial Chain

Figure 65. Medical Biomedical Materials 3.0 Manufacturing Cost Structure

Figure 66. Channels of Distribution (Direct Sales, and Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions